Thrombelastographic evaluation of the influence of 2-RBC apheresis on donor's coagulation system

Transfusion and Apheresis Science

Volumn 48, Issue 3, 2013, Pages 387-390

  Akay, Olga Meltem ^a   Karagulle, Mustafa ^a   Kus, Gokhan ^a   Mutlu, Fezan Sahin ^a   Gunduz, Eren ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Apheresis; Coagulation system; Donor

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD DONOR; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY;

ADULT; AUTOMATION; BLOOD COAGULATION; BLOOD COMPONENT REMOVAL; BLOOD DONORS; ERYTHROCYTES; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; RISK; THROMBELASTOGRAPHY; THROMBOPHILIA; THROMBOSIS; TIME FACTORS; YOUNG ADULT;

EID: 84878820162     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.04.023     Document Type: Article

References (26)

1. Smith J.W., Gilcher R.O. The future of automated red blood cell collection. Transfus Apher Sci 2006, 34:219-226.
2. Popovsky M.A. Safety of RBC apheresis and whole blood donation in allogeneic and autologous blood donors. Transfus Apher Sci 2006, 34:205-211.
3. Sweeney J.D. Standardization of the red cell product. Transfus Apher Sci 2006, 34:213-218.
4. Karadogan I., Ozdogan M., Undar L. Single automated donor plateletpheresis increases the plasma level of proinflammatory cytokine tumor necrosis factor-α which does not associate with endothelial release markers von Willebrand factor and fibronectin. Transfus Sci 2000, 23:171-175.
5. Kobayashi I., Hamaoka S., Ozawa H., Ihno M., Tamura K., Tanaka Y., et al. Hypercoagulable state induced by thrombocytapheresis. J Clin Apheresis 1993, 8:147-152.
6. Ziemer S., Roeseler E., Monike A., Gromnica-Ihle E. Therapeutic plasmapheresis and haemostatic system. Folia Haematol Int Mag Klin Morphol Blutforcsh 1998, 115(4):563-568.
7. Blasi U., Jung F., Mrowietz C., Kiesewetter H., Pindur G., Wendel E. Determination of platelet aggregation of donor blood before and after thrombocytapheresis. Beitr Infusionsther Transfusionmed 1994, 32:339-340.
8. Boehlen F., Michel M., Reber G., de Moerloose P. Analysis of platelet donors function before and after thrombapheresis using the platelet function analyzer PFA-100. Thromb Res 2001, 102:49-52.
9. Akay O.M., Ustuner Z., Canturk Z., Mutlu F.S., Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol 2008, 26(3):358-364.
10. Cimenti C., Sipurzynski S., Gallistl S., Rosenkranz A., Hiden M., Leschnik B., et al. Thrombin generation before and after multicomponent blood collection. Transfusion 2008, 48(8):1584-1590.
11. Bueno J.L. Do we really know the real risks of apheresis donation?. ISBT Sci Ser 2007, 2:68-74.
12. Stohlawetz P., Kapiotis S., Seidl D., Hergovich N., Zellner M., Eichler H.G. Safety issues of plateletpheresis: comparisions of the effects of two cell seperators on the activation of coagulation, fibrinolysis and neutrophils and on the formation of neutrophil-platelet aggregates. Transfusion 1999, 39:420-427.
13. Powner D.J. Thromboelastography during adult donor care. Prog Transplant 2010, 20(2):163-167.
14. Spiel A.O., Mayr F.B., Firbas C., Ouehenberger P., Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2005, 4:411-416.
15. Howland W.S., Castro E.B., Fortner J.B., Gould R.N. Hypercoagulability, thrombelastographic monitoring during extensive hepatic surgery. Arch Surg 1974, 108:605-608.
16. Butler M.J. Thromboelastography during and after elective abdominal surgery. Thromb Hemostas 1978, 39:488-495.
17. Mahla E., Lang T., Vicenzi M.N., Werkgartner G., Maier R., Probst C., et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anest Analg 2001, 92:572-577.
18. Goh K.U.C., Tsio W.C. Hemostatic changes during surgery for primary brain tumors. J Neurol Neurosurg Psychiatry 1997, 63:334-338.
19. Artang R., Jensen E., Pedersen F., Frandsen N.J. Thrombelastography in healthy volunteers, patients with stable angina and acute chest pain. Thromb Res 2000, 97:499-503.
20. Holloway D.S., Vagher J.P., Caprini J.A., Simon N.M., Mockros L.F. Thromboelastography of blood from subjects with chronic renal failure. Thromb Res 1987, 45:817-825.
21. Spillert C.R., McGovern P.J., Vidaver R.M., Lazaro E.J. Thrombelastographic evaluation of cut-down induced accelerated coagulation. Thromb Hemostas 1981, 46:567.
22. Fisch I.R., Freedman S.H. Oral contraceptives, ABO blood groups, and in vitro fibrin formation. Obstet Gynecol 1975, 46(4):473-479.
23. Parvez Z., Moncada R., Fareed J., Messmore H.L. Effect of non-ionic contrast media on the components of coagulation and complement systems. Invest Radiol 1983, 18:279-284.
24. Caprini J.A., Zuckerman L., Cohen A., Vagher J.P., Lipp V. The identification of accelerated coagulability. Thromb Res 1976, 9:167-180.
25. Cohen E., Caprini J.A., Zuckerman L., Vagher J.P., Robinson B. Evaluation of three methods used to identify accelerated coagulability. Thromb Res 1977, 10:587-604.
26. Francis J.L., Francis D.A., Gunathilagan G.J. Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer™ and Thrombelastography. Thromb Res 1994, 74:335-346.